Published Date: November, 2017
The report on global tumor ablation market is an in depth analysis of the segments and sub-segments in the tumor ablation market. The report provides analysis for the global as well as regional markets over the period of 2015 to 2023. According to report the global tumor ablation market is expected to grow at a CAGR of 10.5% over the forecast period of 2017 - 2023.
Figure 1: Global Tumor Ablation Market by Value 2015 - 2023
The report on global tumor ablation market covers segments such as technology, treatment, and application. The technology segments include radiofrequency ablation, microwave ablation, cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation and others. On the basis of treatment, the global tumor ablation market is categorized into surgical ablation, percutaneous ablation and laparoscopic ablation. Furthermore, on the basis of application the tumor ablation market is segmented as liver cancer, lung cancer, kidney cancer, bone metastasis, and other application .
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.
Figure 2: Global Tumor Ablation Market by Region, CAGR %, 2017-2023
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, and among others. Moreover, The European region covers countries such as, Germany, UK, France, Spain and Rest of Europe. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017 - 2023.
The report provides profiles of the companies in the global tumor ablation market such as, Boston Scientific Corp., Angiodynamics, Inc., BVM Medical Limited, Galil Medical, Inc., EDAP TMS S.A., Healthtronics, Inc., INTIO Inc., Mermaid Medical, Inc., Mesonix, Inc., and Medtronic, Plc.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global tumor ablation market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of tumor ablation market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the tumor ablation market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.
This report will help manufacturers, suppliers and distributors of the tumor ablation market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Tumor Ablation Market Overview
3.2 Market Dynamics
3.3 Porter’s Five Forces Analysis
3.4 IGR – Growth Matrix Analysis
3.5 Competitive Landscape in the global Tumor Ablation Market
4. Global Tumor Ablation Market by Technology 2017 - 2023
4.1 Radiofrequency Ablation
4.2 Microwave Ablation
4.4 High-Intensity Focused Ultrasound
4.5 Laser Interstitial Thermal Ablation
5. Global Tumor Ablation Market by Treatment 2017 - 2023
5.1 Surgical Ablation
5.2 Percutaneous Ablation
5.3 Laparoscopic Ablation
6. Global Tumor Ablation Market by Application 2017 - 2023
6.1 Liver Cancer
6.2 Lung Cancer
6.3 Kidney Cancer
6.4 Bone Metastasis
6.5 Other Application
7. Global Tumor Ablation Market by Regions 2017 - 2023
7.1 7.1 North America
7.1.1 North America Tumor Ablation Market by Technology
7.1.2 North America Tumor Ablation Market by Treatment
7.1.3 North America Tumor Ablation Market by Application
7.1.4 North America Tumor Ablation Market by Country
7.2.1 Europe Tumor Ablation Market by Technology
7.2.2 Europe Tumor Ablation Market by Treatment
7.2.3 Europe Tumor Ablation Market by Application
7.2.4 Europe Tumor Ablation Market by
7.3.1 Asia-Pacific Tumor Ablation Market by Technology
7.3.2 Asia-Pacific Tumor Ablation Market by Treatment
7.3.3 Asia-Pacific Tumor Ablation Market by Application
7.3.4 Asia-Pacific Tumor Ablation Market by Country
7.4.1 RoW Tumor Ablation Market by Technology
7.4.2 RoW Tumor Ablation Market by Treatment
7.4.3 RoW Tumor Ablation Market by Application
7.4.4 RoW Tumor Ablation Market by Sub-region
8. Companies Covered
8.1 Boston Scientific Corp.
8.2 Angiodynamics, Inc.
8.3 BVM Medical Limited
8.4 Galil Medical, Inc.
8.5 EDAP TMS S.A.
8.6 Healthtronics, Inc.
8.7 INTIO Inc.
8.8 Mermaid Medical, Inc.
8.9 Mesonix, Inc.
8.10 Medtronic, Plc.